136 related articles for article (PubMed ID: 27647778)
1. Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis.
Liu Q; Li XL; Liu JJ; Song XH; Jiang XY; Li W; Zhang H; Pan CQ
J Obstet Gynaecol Res; 2016 Dec; 42(12):1753-1760. PubMed ID: 27647778
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Combined Bipolar Radiofrequency Impedance-Controlled Endometrial Ablation with Levonorgestrel Intrauterine System versus Bipolar Radiofrequency Endometrial Ablation Alone in Women with Abnormal Uterine Bleeding.
Zhao H; Yang B; Feng L; Li H; Shang H; Zhao Z; Dai Y
J Minim Invasive Gynecol; 2020; 27(3):774-780. PubMed ID: 31201942
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Uterine Bleeding Control by Sequential Application of Hysteroscopic Lesion Morcellation and Endometrial Ablation.
Rubino RJ; Roy KH; Presthus J; Trupin S
J Reprod Med; 2017; 62(3-4):102-10. PubMed ID: 30230300
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the NovaSure endometrial ablation procedure in women with uterine cavity length over 10 cm.
Thiel JA; Briggs MM; Pohlman S; Rattray D
J Obstet Gynaecol Can; 2014 Jun; 36(6):491-497. PubMed ID: 24927186
[TBL] [Abstract][Full Text] [Related]
5. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of NovaSure
Philip CA; Le Mitouard M; Maillet L; de Saint-Hilaire P; Huissoud C; Cortet M; Dubernard G
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():46-51. PubMed ID: 29886317
[TBL] [Abstract][Full Text] [Related]
7. Curative effects of two new endometrial ablation procedures using radiofrequency thermocoagulation for the treatment of severe abnormal uterine bleeding.
Yin G; Li J; Zhu T; Chen M
Cell Biochem Biophys; 2013 Jul; 66(3):529-35. PubMed ID: 23325308
[TBL] [Abstract][Full Text] [Related]
8. Endometrial ablation with NovaSure GEA, a pilot study.
Busund B; Erno LE; Grønmark A; Istre O
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
[TBL] [Abstract][Full Text] [Related]
9. One-Year Follow-Up Results of a Multicenter, Single-Arm, Objective Performance Criteria-Controlled International Clinical Study of the Safety and Efficacy of the Minerva Endometrial Ablation System.
Laberge P; Garza-Leal J; Fortin C; Sabbah R; Fulop T; Pásztor N; Bacsko G
J Minim Invasive Gynecol; 2015; 22(7):1169-77. PubMed ID: 26072204
[TBL] [Abstract][Full Text] [Related]
10. Endometrial ablation with the NovaSure system in Iran.
Asgari Z; Moini A; Samiee H; Tehranian A; Mozafar-Jalali S; Sabet S
Int J Gynaecol Obstet; 2011 Jul; 114(1):73-5. PubMed ID: 21507403
[TBL] [Abstract][Full Text] [Related]
11. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
[TBL] [Abstract][Full Text] [Related]
12. [Clinical observation of microwave endometrial ablation for treatment of abnormal uterine bleeding].
Wang HL; Zhang X; Chen SQ; Yang YF; Sun XZ; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):445-8. PubMed ID: 16080868
[TBL] [Abstract][Full Text] [Related]
13. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia.
Cooper J; Gimpelson R; Laberge P; Galen D; Garza-Leal JG; Scott J; Leyland N; Martyn P; Liu J
J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):418-28. PubMed ID: 12386350
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.
Scordalakes C; delRosario R; Shimer A; Stankiewicz R
Int J Womens Health; 2018; 10():137-145. PubMed ID: 29713204
[TBL] [Abstract][Full Text] [Related]
15. Endometrial Ablation in Women With Abnormal Uterine Bleeding Related to Ovulatory Dysfunction: A Cohort Study.
Hokenstad AN; El-Nashar SA; Khan Z; Hopkins MR; Famuyide AO
J Minim Invasive Gynecol; 2015; 22(7):1225-30. PubMed ID: 26149205
[TBL] [Abstract][Full Text] [Related]
16. [Application of Navosure impedance controlled endometrial ablation system in treating the intrauterine disease].
Zhu W; Mao J; Liu X
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(7):515-8. PubMed ID: 25916927
[TBL] [Abstract][Full Text] [Related]
17. NovaSure radiofrequency endometrial ablation for the management of acute abnormal uterine bleeding.
Al-Inizi S
Int J Gynaecol Obstet; 2017 Nov; 139(2):247-248. PubMed ID: 28795408
[No Abstract] [Full Text] [Related]
18. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Abbott J; Hawe J; Hunter D; Garry R
Fertil Steril; 2003 Jul; 80(1):203-8. PubMed ID: 12849825
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.
Xie H; Wan Y; Yi S; Zeng F; Sun X; Yang Y; Xiao S
Int J Gynaecol Obstet; 2022 Aug; 158(2):301-307. PubMed ID: 34653258
[TBL] [Abstract][Full Text] [Related]
20. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
Fulop T; Rákóczi I; Barna I
J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]